Structure of the POZ domain of human LRF, a master regulator of oncogenesis

Biochemical and Biophysical Research Communications

Volumn 351, Issue 1, 2006, Pages 1-6

  Schubot, Florian D ^a   Tropea, Joseph E ^a   Waugh, David S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

BCL6; BTB; FBI 1; Kr ppel; LRF; PLZF; POK; Pokemon; POZ; SMRT

Indexed keywords

LEUKEMIA LYMPHOMA RELATED FACTOR; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN BCL 6; REPRESSOR PROTEIN; SMRT PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ARTICLE; CARCINOGENESIS; CRYSTAL STRUCTURE; GENE REPRESSION; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; BINDING SITES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTION FACTORS;

EID: 33750290236     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.09.167     Document Type: Article

References (33)

1. Davies J.M., Hawe N., Kabarowski J., Huang Q.H., Zhu J., Brand N.J., Leprince D., Dhordain P., Cook M., Morriss-Kay G., and Zelent A. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene 18 (1999) 365-375
2. Phan R.T., and Dalla-Favera R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 432 (2004) 635-639
3. Barna M., Hawe N., Niswander L., and Pandolfi P.P. Plzf regulates limb and axial skeletal patterning. Nat. Genet. 25 (2000) 166-172
4. Pasqualucci L., Bereschenko O., Niu H., Klein U., Basso K., Guglielmino R., Cattoretti G., and Dalla-Favera R. Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6. Leuk. Lymphoma 44 (2003) S5-S12
5. Deweindt C., Albagli O., Bernardin F., Dhordain P., Quief S., Lantoine D., Kerckaert J.P., and Leprince D. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain. Cell Growth Differ.: Mol. Biol. J. Am. Assoc. Cancer Res. 6 (1995) 1495-1503
6. Shaffer A.L., Yu X., He Y., Boldrick J., Chan E.P., and Staudt L.M. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 13 (2000) 199-212
7. Zelent A. Translocation of the RAR alpha locus to the PML or PLZF gene in acute promyelocytic leukaemia. Br. J. Haematol. 86 (1994) 451-460
8. Maeda T., Hobbs R.M., and Pandolfi P.P. The transcription factor Pokemon: a new key player in cancer pathogenesis. Cancer Res. 65 (2005) 8575-8578
9. Maeda T., Hobbs R.M., Merghoub T., Guernah I., Zelent A., Cordon-Cardo C., Teruya-Feldstein J., and Pandolfi P.P. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 433 (2005) 278-285
10. Bardwell V.J., and Treisman R. The POZ domain: a conserved protein-protein interaction motif. Genes Dev. 8 (1994) 1664-1677
11. Wong C.W., and Privalsky M.L. Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6. J. Biol. Chem. 273 (1998) 27695-27702
12. Dhordain P., Lin R.J., Quief S., Lantoine D., Kerckaert J.P., Evans R.M., and Albagli O. The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression. Nucleic Acids Res. 26 (1998) 4645-4651
13. Huynh K.D., Fischle W., Verdin E., and Bardwell V.J. BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev. 14 (2000) 1810-1823
14. David G., Alland L., Hong S.H., Wong C.W., DePinho R.A., and Dejean A. Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene 16 (1998) 2549-2556
15. Lemercier C., Brocard M.P., Puvion-Dutilleul F., Kao H.Y., Albagli O., and Khochbin S. Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor. J. Biol. Chem. 277 (2002) 22045-22052
16. Ahmad K.F., Melnick A., Lax S., Bouchard D., Liu J., Kiang C.L., Mayer S., Takahashi S., Licht J.D., and Privâe G.G. Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain. Mol. Cell 12 (2003) 1551-1564
17. Ahmad K.F., Engel C.K., and Privâe G.G. Crystal structure of the BTB domain from PLZF. Proc. Natl. Acad. Sci. USA 95 (1998) 12123-12128
18. Li X., Peng H., Schultz D.C., Lopez-Guisa J.M., Rauscher III F.J., and Marmorstein R. Structure-function studies of the BTB/POZ transcriptional repression domain from the promyelocytic leukemia zinc finger oncoprotein. Cancer Res. 59 (1999) 5275-5282
19. Otwinowski Z.M. W., HKL2000. Methods Enzymol. 276 (1997) 307-326
20. McCoy A.J., Grosse-Kunstleve R.W., Storoni L.C., and Read R.J. Likelihood-enhanced fast translation functions. Acta Crystallogr. D, Biol. Crystallogr. 61 (2005) 458-464
21. Jones T.A., Zou J.-Y., Cowan S.W., and Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47 (1991) 110-119
22. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D 53 (1997) 240-255
23. S.D. Laboratory, Collaborative Computational Project, No. 4. 1994, The CCP4 suite: programs for protein crystallography, Acta Crystallogr. D 50 (1994) 760-763.
24. Perrakis A., Morris R., and Lamzin V.S. Automated protein model building combined with iterative structure refinement. Nat. Struct. Biol. 6 (1999) 458-463
25. Laskowski R.A., MacArthur M.W., Moss D.S., and Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26 (1993) 283-291
26. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., and Bourne P.E. The Protein Data Bank. Nucleic Acids Res. 28 (2000) 235-242
27. Melnick A., Carlile G., Ahmad K.F., Kiang C.L., Corcoran C., Bardwell V., Prive G.G., and Licht J.D. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors. Mol. Cell. Biol. 22 (2002) 1804-1818
28. Terwilliger T.C., and Berendzen J. Automated MAD and MIR structure solution. Acta Crystallogr. D 55 Pt 4 (1999) 849-861
29. Dhordain P., Albagli O., Honore N., Guidez F., Lantoine D., Schmid M., Zelent H.D.A., and Koken M.H. Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF. Oncogene 19 (2000) 6240-6250
30. Polo J.M., Dell'Oso T., Ranuncolo S.M., Cerchietti L., Beck D., Da Silva G.F., Prive G.G., Licht J.D., and Melnick A. Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells. Nat. Med. 10 (2004) 1329-1335
31. Brunger A.T. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355 (1992) 472-475
32. Gouet P., Courcelle E., Stuart D.I., and Metoz F. ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics 15 (1999) 305-308
33. W.L. DeLano, The PyMOL Molecular Graphics System., DeLano Scientific LLC, San Carlos, CA, USA, 2001. http://www.pymol.org.